Showing results (2481-2490 of 2,828) with videos related to
Sort By:
Pageof 283
ESMO Open|June 12, 2025
Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM)A Rossi, A G Leone, M Lambertini, et al.Bioorganic & Medicinal Chemistry|April 14, 2016
Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime groupJames R Corte, Tianan Fang, Donald J P Pinto, et al.Journal of Endocrinological Investigation|March 9, 2021
Anti-inflammatory effects of diet and caloric restriction in metabolic syndromeL Montefusco, F D'Addio, C Loretelli, et al.Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT(2C) receptor agonistsGuohua Zhao, Chet Kwon, Sharon N Bisaha, et al.Neurology|January 28, 2004
Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosumC Casali, E M Valente, E Bertini, et al.Journal of Medicinal Chemistry|January 11, 2014
Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitorsMimi L Quan, Pancras C Wong, Cailan Wang, et al.Biorxiv : the Preprint Server for Biology|March 10, 2025
Esr1-Dependent Signaling and Transcriptional Maturation in the Medial Preoptic Area of the Hypothalamus Shapes the Development of Mating Behavior during AdolescenceKoichi Hashikawa, Yoshiko Hashikawa, Brandy Briones, et al.Bioorganic & Medicinal Chemistry Letters|July 9, 2017
Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potencyJames R Corte, Wu Yang, Tianan Fang, et al.Journal of Medicinal Chemistry|December 4, 2003
Discovery of 1-(2-aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2'-(aminosulfonyl)[1,1'-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a potent, selective, and orally bioavailable factor Xa inhibitor(1)James R Pruitt, Donald J P Pinto, Robert A Galemmo, et al.Diabetes, Obesity & Metabolism|July 6, 2016
Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primatesS J Henderson, A Konkar, D C Hornigold, et al.Pageof 283